PI3K Pathway Activation Markers in ER-Positive, HER2-Negative Breast Cancer: A Clinicopathologic Study
Clinical trial NCT07387861 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07387861
- Sponsor
- Assiut University
- Status
- NOT_YET_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2026-03-01
- Primary completion
- 2028-01-01
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.